LPRI-CF113 Endometriosis
Research type
Research Study
Full title
A multicentre, phase III, double-blind, randomised clinical trial to assess the efficacy and safety of LPRI-CF113 in the treatment of Endometriosis versus placebo after 3 medication cycles followed by 3 open-label medication cycles
IRAS ID
1005172
Contact name
Enrico Colli
Contact email
Sponsor organisation
Chemo Research S. L.
Eudract number
2021-001424-17
Research summary
The study is aiming to test whether LPRI-CF113 can help in Endometriosis patients within 6 cycles
REC name
East of England - Cambridge South Research Ethics Committee
REC reference
22/EE/0159
Date of REC Opinion
12 Oct 2022
REC opinion
Further Information Favourable Opinion